Parliamentary Search

Written question asked by Jonathan Davies (Labour) on Wednesday, 13 May 2026, in the House of Commons. It was due for an answer on Monday, 18 May 2026. It was answered by Preet Kaur Gill (Labour) on Friday, 22 May 2026 on behalf of the Department of Health and Social Care.

Hormone Replacement Therapy

Question

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support women who require hormone replacement therapy medication for management of long-term health conditions.

Answer

We recognise the significant impact that menopause symptoms can have on women’s health, wellbeing, and daily lives. Improving support for women experiencing menopause is an important part of the Government’s wider work on women’s health.

The hormone replacement therapy (HRT) prescription prepayment certificate covers eligible HRT medicines containing oestrogen and/or progesterone that are licensed for the treatment of menopause. It is valid for 12 months, costs £19.80, and can reduce costs for patients who need more than one prescription.

As announced in October, local authorities will be asked to include menopause in the NHS Health Check later this year. This will signpost eligible women in England to information on menopause, including symptom management, support, and diagnosis. Menopause and menstrual health conditions will also be priorities for the National Health Service’s new online hospital, due to launch next year, to improve access to specialist care.

Secondary information

Type
Written question
Reference
638
Session
2026-27
Subjects
Hormone replacement therapy
Link
View this Written question on www.parliament.uk